BACKGROUND AND PURPOSE: Reports describing functional neuroimaging techniques, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), in sporadic Creutzfeldt-Jakob disease (sCJD) have consistently suggested that these tools are sensitive for the identification of areas of hypoperfusion or hypometabolism, even in the early stages of sCJD. However, there are few reports on the use of [18F]fluoro-2-deoxy-D-glucose (FDG) PET in sCJD, and most of them are single case reports. Only two small cohort studies based on visual inspection or a region of interest method have been published to date. Using a statistical parametric mapping (SPM) analysis of (18) F-FDG PET, we investigated whether there are brain regions preferentially affected in sCJD. METHODS: After controlling for age and gender, using SPM 2, we compared the glucose metabolism between (i) 11 patients with sCJD and 35 controls and (ii) the subset of five patients with the Heidenhain variant of sCJD and 35 controls. RESULTS: The patients with sCJD showed decreased glucose metabolism in bilateral parietal, frontal and occipital cortices. The Heidenhain variant of sCJD showed glucose hypometabolism mainly in bilateral occipital areas. CONCLUSIONS: Glucose hypometabolism in sCJD was detected in extensive cortical regions; however, it was not found in the basal ganglia or thalamus, which are frequently reported to be affected on diffusion-weighted images. The medial temporal area, which is possibly resistant to the prion deposits, was also less involved in sCJD.
BACKGROUND AND PURPOSE: Reports describing functional neuroimaging techniques, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), in sporadic Creutzfeldt-Jakob disease (sCJD) have consistently suggested that these tools are sensitive for the identification of areas of hypoperfusion or hypometabolism, even in the early stages of sCJD. However, there are few reports on the use of [18F]fluoro-2-deoxy-D-glucose (FDG) PET in sCJD, and most of them are single case reports. Only two small cohort studies based on visual inspection or a region of interest method have been published to date. Using a statistical parametric mapping (SPM) analysis of (18) F-FDG PET, we investigated whether there are brain regions preferentially affected in sCJD. METHODS: After controlling for age and gender, using SPM 2, we compared the glucose metabolism between (i) 11 patients with sCJD and 35 controls and (ii) the subset of five patients with the Heidenhain variant of sCJD and 35 controls. RESULTS: The patients with sCJD showed decreased glucose metabolism in bilateral parietal, frontal and occipital cortices. The Heidenhain variant of sCJD showed glucose hypometabolism mainly in bilateral occipital areas. CONCLUSIONS:Glucose hypometabolism in sCJD was detected in extensive cortical regions; however, it was not found in the basal ganglia or thalamus, which are frequently reported to be affected on diffusion-weighted images. The medial temporal area, which is possibly resistant to the prion deposits, was also less involved in sCJD.
Authors: T Hamaguchi; T Kitamoto; T Sato; H Mizusawa; Y Nakamura; M Noguchi; Y Furukawa; C Ishida; I Kuji; K Mitani; S Murayama; T Kohriyama; S Katayama; M Yamashita; T Yamamoto; F Udaka; A Kawakami; Y Ihara; T Nishinaka; S Kuroda; N Suzuki; Y Shiga; H Arai; M Maruyama; M Yamada Journal: Neurology Date: 2005-02-22 Impact factor: 9.910
Authors: Robert Pichler; Ioana Ciovica; Johanna Rachinger; Serge Weiss; Franz T Aichner Journal: Neuro Endocrinol Lett Date: 2008-02 Impact factor: 0.765
Authors: H J Tschampa; K Kallenberg; H A Kretzschmar; B Meissner; M Knauth; H Urbach; I Zerr Journal: AJNR Am J Neuroradiol Date: 2007 Jun-Jul Impact factor: 3.825
Authors: Geoffrey S Young; Michael D Geschwind; Nancy J Fischbein; Jennifer L Martindale; Roland G Henry; Songling Liu; Ying Lu; Stephen Wong; Hong Liu; Bruce L Miller; William P Dillon Journal: AJNR Am J Neuroradiol Date: 2005 Jun-Jul Impact factor: 3.825
Authors: P Vitali; E Maccagnano; E Caverzasi; R G Henry; A Haman; C Torres-Chae; D Y Johnson; B L Miller; M D Geschwind Journal: Neurology Date: 2011-04-06 Impact factor: 9.910
Authors: Elena Prieto; Inés Domínguez-Prado; Mario Riverol; Sara Ortega-Cubero; María Jesús Ribelles; María Rosario Luquin; Purificación de Castro; Javier Arbizu Journal: Eur J Nucl Med Mol Imaging Date: 2015-06-04 Impact factor: 9.236
Authors: Jordi A Matías-Guiu; Carmen Guerrero-Márquez; María Nieves Cabrera-Martín; Ulises Gómez-Pinedo; María Romeral; Diego Mayo; Jesús Porta-Etessam; Teresa Moreno-Ramos; José Luis Carreras; Jorge Matías-Guiu Journal: Prion Date: 2017-05-16 Impact factor: 3.931
Authors: Julie-Myrtille Bourgognon; Jereme G Spiers; Hannah Scheiblich; Alexey Antonov; Sophie J Bradley; Andrew B Tobin; Joern R Steinert Journal: Cell Death Differ Date: 2018-06-18 Impact factor: 15.828
Authors: Karin P Mente; James K O'Donnell; Stephen E Jones; Mark L Cohen; Nicolas R Thompson; Alberto Bizzi; Pierluigi Gambetti; Jiri G Safar; Brian S Appleby Journal: Alzheimer Dis Assoc Disord Date: 2017 Jan-Mar Impact factor: 2.703